Skip to content
OpenCapital
Get started

AngioDynamics ANGO Operating Income

Operating Income at other companies

Abbott logo
AbbottABT
$1.35B-20.6%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$93M-75.7%
TFX
TeleflexTFX
$20.18M-73.4%
Stryker logo
StrykerSYK
$936M+11.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$44.16M+7.6%
ICU Medical logo
ICU MedicalICUI
$13.58M+5.4%

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%—

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0×0.0×
Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's operating income?
AngioDynamics (ANGO) reported operating income of -$12.95M in Q4 2025.
How has AngioDynamics's operating income changed year-over-year?
AngioDynamics's operating income decreased by 29.8% year-over-year, from -$9.97M to -$12.95M.
What is the long-term trend for AngioDynamics's operating income?
Over 4 years (2021 to 2025), AngioDynamics's operating income has grown at a 3.2% compound annual growth rate (CAGR), from -$35.28M to -$39.95M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.